A Study in Subjects With Advanced Solid Tumors

NCT04156100 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic business decision.

Conditions

Advanced Solid Tumor

Interventions

DRUG: AGEN1223
DRUG: AGEN1223 and balstilimab

Sponsor

Agenus Inc.